SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950129-00-001556
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
12
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 ARONEX PHARMACEUTICALS, INC. - DATED 12/31/1999 10-K405 287342
2 4TH AMENDMENT TO REGISTRATION RIGHTS AGREEMENT EX-10.5 9727
3 COMMON STOCK PURCHASE WARRANT - DATED 06/28/1993 EX-10.18 35334
4 COMMON STOCK PURCHASE WARRANT - DATED 03/21/1994 EX-10.19 35554
5 COMMON STOCK PURCHASE WARRANT - DATED 06/28/1993 EX-10.20 35362
6 COMMON STOCK PURCHASE WARRANT - DATED 03/21/1994 EX-10.21 35469
7 FORM OF CERTIFICATE OF CONTINGENT INTEREST EX-10.26 17032
8 EMPLOYMENT AGREEMENT - DATED OCTOBER 6, 1999 EX-10.37 24344
9 EMPLOYMENT AGREEMENT - DATED DECEMBER 1, 1999 EX-10.38 25051
10 STATEMENT REGARDING COMPUTATION OF LOSS PER SHARE EX-11.1 8421
11 CONSENT OF ARTHUR ANDERSEN LLP EX-23.1 586
12 FINANCIAL DATA SCHEDULE EX-27.1 2336
  Complete submission text file 0000950129-00-001556.txt   519377
Mailing Address 8707 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381-1191
Business Address 8707 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381-1191 2813671666
ARONEX PHARMACEUTICALS INC (Filer) CIK: 0000854691 (see all company filings)

IRS No.: 760196535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-20111 | Film No.: 588807
SIC: 2834 Pharmaceutical Preparations